GlassScriptPhysician profile
Federico R Ng
NPI 1528061488
$4,892.53
in general payments reported to CMS, 2019-2025
41 companies · $586 in 2025
The $586 reported for 2025 was more than what 76% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $329 · 2020: $466 · 2021: $783 · 2022: $1,223 · 2023: $971 · 2024: $535 · 2025: $586.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,091.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,091.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $656.04 | 2021-2024 | |
| Glaxosmithkline, LLC. | $645.65 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Astrazeneca Pharmaceuticals LP | $619.42 | 2020-2025 | Airsupra, Breztri, Farxiga |
| Novo Nordisk INC | $394.08 | 2020-2024 | Rybelsus, Ozempic, Wegovy |
| Ironshore Pharmaceuticals INC. | $262.37 | 2019-2024 | Jornay Pm |
| Lilly USA, LLC | $233.60 | 2019-2025 | Mounjaro |
| Takeda Pharmaceuticals U.S.A., INC. | $210.64 | 2021-2025 | Trintellix |
| Collegium Pharmaceutical, INC. | $183.93 | 2025 | Jornay Pm |
| Acerus Pharmaceuticals Corporation | $168.64 | 2021-2022 | |
| Lundbeck LLC | $149.73 | 2023 | Vyepti |
| Bayer Healthcare Pharmaceuticals INC. | $143.85 | 2023-2025 | |
| Genentech USA, INC. | $118.11 | 2020-2021 | |
| Neos Therapeutics, LP | $109.53 | 2019-2021 | |
| Abbott Laboratories | $105.95 | 2021-2023 | Freestyle Libre 3 |
| Antares Pharma, INC. | $102.03 | 2019-2022 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Federico Ng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.